Novartis RNA pullback gives biotech stocks whiplash | PharmaBoardroom
written on 15.04.2014
Tags:
,

Novartis RNA pullback gives biotech stocks whiplash

TAGS: ,

Already trading near its recent one-year high of $85.23 per share, Novartis closed up 1.4% at $83.83, but the company also owns 13% of Alnylam whose stock fell 2.8% to $53.54.

Latest Report